-
1
-
-
33749034730
-
Topoisomerase i Inhibitors: Camptothecins and beyond
-
Pommier, E. Topoisomerase I Inhibitors: Camptothecins and Beyond. Nat. Rev. Cancer 2006, 6, 789-802.
-
(2006)
Nat. Rev. Cancer
, vol.6
, pp. 789-802
-
-
Pommier, E.1
-
2
-
-
0034923502
-
DNA Topoisomerases: Structure, function, and mechanism
-
Champoux, J. J. DNA Topoisomerases: Structure, Function, and Mechanism. Annu. Rev. Biochem. 2001, 70, 369-413.
-
(2001)
Annu. Rev. Biochem.
, vol.70
, pp. 369-413
-
-
Champoux, J.J.1
-
3
-
-
0035098297
-
Modulation of camptothecin analogs in the treatment of cancer: A review
-
Kehrer, D. F. S.; Soepenberg, O.; Loos, W.; Verweij, J.; Sparreboom, A. Modulation of Camptothecin Analogs in the Treatment of Cancer: A Review. Anti-Cancer Drugs 2001, 12, 89-105.
-
(2001)
Anti-Cancer Drugs
, vol.12
, pp. 89-105
-
-
Kehrer, D.F.S.1
Soepenberg, O.2
Loos, W.3
Verweij, J.4
Sparreboom, A.5
-
4
-
-
0036304427
-
Current perspectives on the clinical experience, pharmacology, and continued development of the camptothecins
-
Garcia-Carbonero, R.; Supko, J. G. Current Perspectives on the Clinical Experience, Pharmacology, and Continued Development of the Camptothecins. Clin. Cancer Res. 2002, 8, 641-661.
-
(2002)
Clin. Cancer Res.
, vol.8
, pp. 641-661
-
-
Garcia-Carbonero, R.1
Supko, J.G.2
-
5
-
-
0027428116
-
Plasma Pharmacokinetics of the Lactone and Carboxylate Forms of 20(S)-Camptothecin in Anesthetized Rats
-
Scott, D. O.; Bindra, D. S.; Stella, V. J. Plasma Pharmacokinetics of the Lactone and Carboxylate Forms of 20(S)-Camptothecin in Anesthetized Rats. Pharm. Res. 1993, 10, 1451-1457.
-
(1993)
Pharm. Res.
, vol.10
, pp. 1451-1457
-
-
Scott, D.O.1
Bindra, D.S.2
Stella, V.J.3
-
6
-
-
0028012774
-
The structural basis of camptothecin interactions with human serum-albumin. Impact on drug stability
-
Burke, T. G.; Mi, Z. H. The Structural Basis of Camptothecin Interactions with Human Serum-Albumin. Impact on Drug Stability. J. Med. Chem. 1994, 37, 40-46.
-
(1994)
J. Med. Chem.
, vol.37
, pp. 40-46
-
-
Burke, T.G.1
Mi, Z.H.2
-
7
-
-
0023924786
-
Identification of Mammalian DNA Topoisomerase-I as an Intracellular Target of the Anticancer Drug Camptothecin
-
Hsiang, Y. H.; Liu, L. F. Identification of Mammalian DNA Topoisomerase-I as an Intracellular Target of the Anticancer Drug Camptothecin. Cancer Res. 1988, 48, 1722-1726.
-
(1988)
Cancer Res.
, vol.48
, pp. 1722-1726
-
-
Hsiang, Y.H.1
Liu, L.F.2
-
8
-
-
0028957974
-
Mutation at the Catalytic Site of Topoisomerase i in CEM/C2, a Human Leukemia Cell Resistant to Camptothecin
-
Fujimori, A.; Harker, W. G.; Kohlhagen, G.; Hoki, Y.; Pommier, Y. Mutation at the Catalytic Site of Topoisomerase I in CEM/C2, a Human Leukemia Cell Resistant to Camptothecin. Cancer Res. 1995, 55, 1339-1346.
-
(1995)
Cancer Res.
, vol.55
, pp. 1339-1346
-
-
Fujimori, A.1
Harker, W.G.2
Kohlhagen, G.3
Hoki, Y.4
Pommier, Y.5
-
9
-
-
0035266161
-
Characterization of a Novel Topoisomerase i Mutation from a Camptothecin-Resistant Human Prostate Cancer Cell Line
-
Urasaki, Y.; Laco, G. S.; Pourquier, P.; Takebayashi, Y.; Kohlhagen, G.; Gioffre, C.; Zhang, H. L.; Chatterjee, D.; Pantazis, P.; Pommier, Y. Characterization of a Novel Topoisomerase I Mutation from a Camptothecin- Resistant Human Prostate Cancer Cell Line. Cancer Res. 2001, 61, 1964-1969.
-
(2001)
Cancer Res.
, vol.61
, pp. 1964-1969
-
-
Urasaki, Y.1
Laco, G.S.2
Pourquier, P.3
Takebayashi, Y.4
Kohlhagen, G.5
Gioffre, C.6
Zhang, H.L.7
Chatterjee, D.8
Pantazis, P.9
Pommier, Y.10
-
10
-
-
33644755350
-
Molecular modeling of new camptothecin analogues to circumvent ABCG2-mediated drug resistance in cancer
-
Nakagawa, H.; Saito, H.; Ikegami, Y.; Aida-Hyugaji, S.; Seigo, S.; Ishikawa, T. Molecular Modeling of New Camptothecin Analogues To Circumvent ABCG2-Mediated Drug Resistance in Cancer. Cancer Lett. 2006, 234, 81-89.
-
(2006)
Cancer Lett.
, vol.234
, pp. 81-89
-
-
Nakagawa, H.1
Saito, H.2
Ikegami, Y.3
Aida-Hyugaji, S.4
Seigo, S.5
Ishikawa, T.6
-
11
-
-
0032189683
-
Mechanism of action of eukaryotic DNA topoisomerases and drugs targeted to the enzyme
-
Pommier, Y.; Pourquier, P.; Fan, Y.; Strumberg, D. Mechanism of Action of Eukaryotic DNA Topoisomerases and Drugs Targeted to the Enzyme. Biochem. Biophys. Acta 1998, 1400, 83-105.
-
(1998)
Biochem. Biophys. Acta
, vol.1400
, pp. 83-105
-
-
Pommier, Y.1
Pourquier, P.2
Fan, Y.3
Strumberg, D.4
-
12
-
-
0015292126
-
Treatment of Malignant Melanoma with Camptothecin (NSC-100880)
-
Gottlieb, J. A.; Luce, J. K. Treatment of Malignant Melanoma with Camptothecin (NSC-100880). Cancer Chemother. Rep. 1972, 56, 103-105.
-
(1972)
Cancer Chemother. Rep.
, vol.56
, pp. 103-105
-
-
Gottlieb, J.A.1
Luce, J.K.2
-
13
-
-
58749110485
-
DNA Cleavage Assay for the Identification of Topoisomerase i Inhibitors
-
Dexheimer, T. S.; Pommier, Y. DNA Cleavage Assay for the Identification of Topoisomerase I Inhibitors. Nat. Protoc. 2008, 3, 1736-1750.
-
(2008)
Nat. Protoc.
, vol.3
, pp. 1736-1750
-
-
Dexheimer, T.S.1
Pommier, Y.2
-
14
-
-
33745737662
-
Review of camptothecin: Current perspectives
-
Li, Q.-Y.; Zu, Y.-G.; Shi, R.-Z.; Yao, L.-P. Review of Camptothecin: Current Perspectives. Curr. Med. Chem. 2006, 13, 2021-2039.
-
(2006)
Curr. Med. Chem.
, vol.13
, pp. 2021-2039
-
-
Li, Q.-Y.1
Zu, Y.-G.2
Shi, R.-Z.3
Yao, L.-P.4
-
15
-
-
39749119942
-
Next generation of topoisomerase i inhibitors: Rationale and biomarker strategies
-
Teicher, B. Next Generation of Topoisomerase I Inhibitors: Rationale and Biomarker Strategies. Biochem. Pharmacol. 2008, 75, 1262-1271.
-
(2008)
Biochem. Pharmacol.
, vol.75
, pp. 1262-1271
-
-
Teicher, B.1
-
16
-
-
67650682519
-
DNA topoisomerase i inhibitors: Chemistry, biology, and interfacial inhibition
-
Pommier, Y. DNA Topoisomerase I Inhibitors: Chemistry, Biology, and Interfacial Inhibition. Chem. Rev. 2009, 109, 2894-2902.
-
(2009)
Chem. Rev.
, vol.109
, pp. 2894-2902
-
-
Pommier, Y.1
-
17
-
-
66849113688
-
The indenoisoquinoline noncamptothecin topoisomerase i inhibitors: Update and perspectives
-
Pommier, Y.; Cushman, M. The Indenoisoquinoline Noncamptothecin Topoisomerase I Inhibitors: Update and Perspectives. Mol. Cancer Ther. 2009, 8, 1008-1014.
-
(2009)
Mol. Cancer Ther.
, vol.8
, pp. 1008-1014
-
-
Pommier, Y.1
Cushman, M.2
-
18
-
-
33646477959
-
Phase i and pharmacokinetic study of edotecarin, a Novel topoisomerase i inhibitor, administered once every 3 weeks in patients with solid tumors
-
Yamada, Y.; Tamura, T.; Yamamoto, N.; Shimoyama, T.; Ueda, Y.; Murakami, H.; Kusaba, H.; Kamiya, Y.; Saka, H.; Tanigawara, Y.; McGovren, J. P.; Natsumeda, Y. Phase I and Pharmacokinetic Study of Edotecarin, a Novel Topoisomerase I Inhibitor, Administered Once Every 3 Weeks in Patients with Solid Tumors. Cancer Chemother. Pharmacol. 2006, 58, 173-182.
-
(2006)
Cancer Chemother. Pharmacol.
, vol.58
, pp. 173-182
-
-
Yamada, Y.1
Tamura, T.2
Yamamoto, N.3
Shimoyama, T.4
Ueda, Y.5
Murakami, H.6
Kusaba, H.7
Kamiya, Y.8
Saka, H.9
Tanigawara, Y.10
McGovren, J.P.11
Natsumeda, Y.12
-
19
-
-
0031815336
-
Protein-linked DNA strand breaks induced by NSC 314622, a Novel noncamptothecin topoisomerase i poison
-
Kohlhagen, G.; Paull, K.; Cushman, M.; Nagafuji, P.; Pommier, Y. Protein-Linked DNA Strand Breaks Induced by NSC 314622, a Novel Noncamptothecin Topoisomerase I Poison. Mol. Pharmacol. 1998, 54, 50-58.
-
(1998)
Mol. Pharmacol.
, vol.54
, pp. 50-58
-
-
Kohlhagen, G.1
Paull, K.2
Cushman, M.3
Nagafuji, P.4
Pommier, Y.5
-
20
-
-
0034609859
-
Synthesis of new indeno[l,2-c]isoquinolines: Cytotoxic non-camptothecin topoisomerase i inhibitors
-
Cushman, M.; Jayaraman, M.; Vroman, J. A.; Fukunaga, A. K.; Fox, B. M.; Kohlhagen, G.; Strumberg, D.; Pommier, Y. Synthesis of New Indeno[l,2-c] isoquinolines: Cytotoxic Non-Camptothecin Topoisomerase I Inhibitors. J. Med. Chem. 2000, 43, 3688-3698.
-
(2000)
J. Med. Chem.
, vol.43
, pp. 3688-3698
-
-
Cushman, M.1
Jayaraman, M.2
Vroman, J.A.3
Fukunaga, A.K.4
Fox, B.M.5
Kohlhagen, G.6
Strumberg, D.7
Pommier, Y.8
-
21
-
-
0038155266
-
Design, synthesis, and biological evaluation of cytotoxic 11-Alkenylindenoisoquinoline topoisomerase i inhibitors and indenoisoquinoline- camptothecin hybrids
-
Fox, B. M.; Xiao, X.; Antony, S.; Kohlhagen, G.; Pommier, Y.; Staker, B. L.; Stewart, L.; Cushman, M. Design, Synthesis, and Biological Evaluation of Cytotoxic 11-Alkenylindenoisoquinoline Topoisomerase I Inhibitors and Indenoisoquinoline-Camptothecin Hybrids. J. Med. Chem. 2003, 46, 3275-3282.
-
(2003)
J. Med. Chem.
, vol.46
, pp. 3275-3282
-
-
Fox, B.M.1
Xiao, X.2
Antony, S.3
Kohlhagen, G.4
Pommier, Y.5
Staker, B.L.6
Stewart, L.7
Cushman, M.8
-
22
-
-
2942596235
-
Synthesis of nitrated indenoisoquinolines as topoisomerase i inhibitors
-
Morrell, A.; Antony, S.; Kohlhagen, G.; Pommier, Y.; Cushman, M. Synthesis of Nitrated Indenoisoquinolines as Topoisomerase I Inhibitors. Bioorg. Med. Chem. Lett. 2004, 14, 3659-3663.
-
(2004)
Bioorg. Med. Chem. Lett.
, vol.14
, pp. 3659-3663
-
-
Morrell, A.1
Antony, S.2
Kohlhagen, G.3
Pommier, Y.4
Cushman, M.5
-
23
-
-
33845955224
-
A systematic study of nitrated indenoisoquinolines reveals a potent topoisomerase i inhibitor
-
Morrell, A.; Antony, S.; Kohlhagen, G.; Pommier, Y.; Cushman, M. A Systematic Study of Nitrated Indenoisoquinolines Reveals a Potent Topoisomerase I Inhibitor. J. Med. Chem. 2006, 49, 77407753.
-
(2006)
J. Med. Chem.
, vol.49
, pp. 77407753
-
-
Morrell, A.1
Antony, S.2
Kohlhagen, G.3
Pommier, Y.4
Cushman, M.5
-
24
-
-
33144472888
-
Synthesis of benz[d]indeno[l,2-b]pyran-5,11-diones: Versatile intermediates for the design and synthesis of topoisomerase i inhibitors
-
Morrell, A.; Antony, S.; Kohlhagen, G.; Pommier, Y.; Cushman, M. Synthesis of Benz[d]indeno[l,2-b]pyran-5,11-diones: Versatile Intermediates for the Design and Synthesis of Topoisomerase I Inhibitors. Bioorg. Med. Chem. Lett. 2006, 16, 1846-1849.
-
(2006)
Bioorg. Med. Chem. Lett.
, vol.16
, pp. 1846-1849
-
-
Morrell, A.1
Antony, S.2
Kohlhagen, G.3
Pommier, Y.4
Cushman, M.5
-
25
-
-
33745837464
-
Evaluation of indenoisoquinoline topoisomerase i inhibitors using a hollow fiber assay
-
Morrell, A.; Jayaraman, M.; Nagarajan, M.; Fox, B. M.; Meckley, M. R.; Ioanoviciu, A.; Pommier, Y.; Antony, S.; Hollineshead, M.; Cushman, M. Evaluation of Indenoisoquinoline Topoisomerase I Inhibitors Using a Hollow Fiber Assay. Bioorg. Med. Chem. Lett. 2006, 16, 4395-4399.
-
(2006)
Bioorg. Med. Chem. Lett.
, vol.16
, pp. 4395-4399
-
-
Morrell, A.1
Jayaraman, M.2
Nagarajan, M.3
Fox, B.M.4
Meckley, M.R.5
Ioanoviciu, A.6
Pommier, Y.7
Antony, S.8
Hollineshead, M.9
Cushman, M.10
-
26
-
-
34548510839
-
Nitrated indenoisoquinolines as topoisomerase i inhibitors: A systematic study and optimization
-
Morrell, A.; Placzek, M.; Parmley, S.; Antony, S.; Dexheimer, T. S.; Pommier, Y.; Cushman, M. Nitrated Indenoisoquinolines as Topoisomerase I Inhibitors: A Systematic Study and Optimization. J. Med. Chem. 2007, 50, 4419-4430.
-
(2007)
J. Med. Chem.
, vol.50
, pp. 4419-4430
-
-
Morrell, A.1
Placzek, M.2
Parmley, S.3
Antony, S.4
Dexheimer, T.S.5
Pommier, Y.6
Cushman, M.7
-
27
-
-
34548504314
-
Optimization of the indenone ring of indenoisoquinoline topoisomerase i inhibitors
-
Morrell, A.; Placzek, M.; Parmley, S.; Grella, B.; Antony, S.; Pommier, Y.; Cushman, M. Optimization of the Indenone Ring of Indenoisoquinoline Topoisomerase I Inhibitors. J. Med. Chem. 2007, 50, 4388-4404.
-
(2007)
J. Med. Chem.
, vol.50
, pp. 4388-4404
-
-
Morrell, A.1
Placzek, M.2
Parmley, S.3
Grella, B.4
Antony, S.5
Pommier, Y.6
Cushman, M.7
-
28
-
-
34247613433
-
Investigation of the lactam side chain length necessary for optimal indenoisoquinoline topoisomerase i inhibition and cytotoxicity in human cancer cell cultures
-
Morrell, A.; Placzek, M. S.; Steffen, J. D.; Antony, S.; Agama, K.; Pommier, Y.; Cushman, M. Investigation of the Lactam Side Chain Length Necessary for Optimal Indenoisoquinoline Topoisomerase I Inhibition and Cytotoxicity in Human Cancer Cell Cultures. J. Med. Chem. 2007, 50, 2040-2048.
-
(2007)
J. Med. Chem.
, vol.50
, pp. 2040-2048
-
-
Morrell, A.1
Placzek, M.S.2
Steffen, J.D.3
Antony, S.4
Agama, K.5
Pommier, Y.6
Cushman, M.7
-
29
-
-
33747470312
-
Synthesis and biological evaluation of bisindenoisoquinolines as topoisomerase i inhibitors
-
Nagarajan, M.; Morrell, A.; Antony, S.; Kohlhagen, G.; Agama, K.; Pommier, Y.; Ragazzon, P. A.; Garbett, N. C.; Chaires, J. B.; Hollingshead, M.; Cushman, M. Synthesis and Biological Evaluation of Bisindenoisoquinolines as Topoisomerase I Inhibitors. J. Med. Chem. 2006, 49, 5129-5140.
-
(2006)
J. Med. Chem.
, vol.49
, pp. 5129-5140
-
-
Nagarajan, M.1
Morrell, A.2
Antony, S.3
Kohlhagen, G.4
Agama, K.5
Pommier, Y.6
Ragazzon, P.A.7
Garbett, N.C.8
Chaires, J.B.9
Hollingshead, M.10
Cushman, M.11
-
30
-
-
7444233119
-
Synthesis and anticancer activity of simplified indenoisoquinoline topoisomerase i inhibitors lacking substituents on the aromatic rings
-
Nagarajan, M.; Morrell, A.; Fort, B. C.; Meckley, M. R.; Antony, S.; Kohlhagen, G.; Pommier, Y.; Cushman, M. Synthesis and Anticancer Activity of Simplified Indenoisoquinoline Topoisomerase I Inhibitors Lacking Substituents on the Aromatic Rings. J. Med. Chem. 2004, 47, 5651-5661.
-
(2004)
J. Med. Chem.
, vol.47
, pp. 5651-5661
-
-
Nagarajan, M.1
Morrell, A.2
Fort, B.C.3
Meckley, M.R.4
Antony, S.5
Kohlhagen, G.6
Pommier, Y.7
Cushman, M.8
-
31
-
-
33750142705
-
Synthesis and evaluation of indenoisoquinoline topoisomerase i inhibitors substituted with nitrogen heterocycles
-
Nagarajan, M.; Morrell, A.; Ioanoviciu, A.; Antony, S.; Kohlhagen, G.; Agama, K.; Hollingshead, M.; Pommier, Y.; Cushman, M. Synthesis and Evaluation of Indenoisoquinoline Topoisomerase I Inhibitors Substituted with Nitrogen Heterocycles. J. Med. Chem. 2006, 49, 6283-6289.
-
(2006)
J. Med. Chem.
, vol.49
, pp. 6283-6289
-
-
Nagarajan, M.1
Morrell, A.2
Ioanoviciu, A.3
Antony, S.4
Kohlhagen, G.5
Agama, K.6
Hollingshead, M.7
Pommier, Y.8
Cushman, M.9
-
32
-
-
0346996356
-
Design, synthesis, and biological evaluation of indenoisoquinoline topoisomerase i inhibitors featuring polyamine side chains on the lactam nitrogen
-
Nagarajan, M.; Xiao, X.; Antony, S.; Kohlhagen, G.; Pommier, Y.; Cushman, M. Design, Synthesis, and Biological Evaluation of Indenoisoquinoline Topoisomerase I Inhibitors Featuring Polyamine Side Chains on the Lactam Nitrogen. J. Med. Chem. 2003, 46, 5712-5724.
-
(2003)
J. Med. Chem.
, vol.46
, pp. 5712-5724
-
-
Nagarajan, M.1
Xiao, X.2
Antony, S.3
Kohlhagen, G.4
Pommier, Y.5
Cushman, M.6
-
33
-
-
0033047992
-
Synthesis of cytotoxic indenoisoquinoline topoisomerase i poisons
-
Strumberg, D.; Pommier, Y.; Paull, K.; Jayaraman, M.; Nagafuji, P.; Cushman, M. Synthesis of Cytotoxic Indenoisoquinoline Topoisomerase I Poisons. J. Med. Chem. 1999, 42, 446-457.
-
(1999)
J. Med. Chem.
, vol.42
, pp. 446-457
-
-
Strumberg, D.1
Pommier, Y.2
Paull, K.3
Jayaraman, M.4
Nagafuji, P.5
Cushman, M.6
-
34
-
-
35948968756
-
Novel indenoisoquinolines NSC 725776 and NSC 724998 produce persistent topoisomerase i cleavage complexes and overcome multidrug resistance
-
Antony, S.; Agama, K. K.; Miao, Z. H.; Takagi, K.; Wright, M. H.; Robles, A. I.; Varticovski, L.; Nagarajan, M.; Morrell, A.; Cushman, M.; Pommier, Y. Novel Indenoisoquinolines NSC 725776 and NSC 724998 Produce Persistent Topoisomerase I Cleavage Complexes and Overcome Multidrug Resistance. Cancer Res. 2007, 67, 1039710405.
-
(2007)
Cancer Res.
, vol.67
, pp. 1039710405
-
-
Antony, S.1
Agama, K.K.2
Miao, Z.H.3
Takagi, K.4
Wright, M.H.5
Robles, A.I.6
Varticovski, L.7
Nagarajan, M.8
Morrell, A.9
Cushman, M.10
Pommier, Y.11
-
35
-
-
22744438407
-
Synthesis and mechanism of action studies of a series of norindenoisoquinoline topoisomerase i poisons reveal an inhibitor with a flipped orientation in the ternary DNAEnzyme-inhibitor complex as determined by x-ray crystallography analysis
-
Ioanoviciu, A.; Antony, S.; Pommier, Y.; Staker, B. L.; Stewart, L.; Cushman, M. Synthesis and Mechanism of Action Studies of a Series of Norindenoisoquinoline Topoisomerase I Poisons Reveal an Inhibitor with a Flipped Orientation in the Ternary DNAEnzyme-Inhibitor Complex As Determined by X-ray Crystallography Analysis. J. Med. Chem. 2005, 48, 4803-4814.
-
(2005)
J. Med. Chem.
, vol.48
, pp. 4803-4814
-
-
Ioanoviciu, A.1
Antony, S.2
Pommier, Y.3
Staker, B.L.4
Stewart, L.5
Cushman, M.6
-
36
-
-
33644970269
-
A novel norindenoisoquinoline structure reveals a common interfacial inhibitor paradigm for ternary trapping of the topoisomerase I-DNA complex
-
Marchand, C.; Antony, S.; Kohn, K. W.; Cushman, M.; Ioanoviciu, A.; Staker, B. L.; Burgin, A.; Stewart, L.; Pommier, Y. A Novel Norindenoisoquinoline Structure Reveals a Common Interfacial Inhibitor Paradigm for Ternary Trapping of the Topoisomerase I-DNA Complex. Mol. Cancer Ther. 2006, 5, 287-295.
-
(2006)
Mol. Cancer Ther.
, vol.5
, pp. 287-295
-
-
Marchand, C.1
Antony, S.2
Kohn, K.W.3
Cushman, M.4
Ioanoviciu, A.5
Staker, B.L.6
Burgin, A.7
Stewart, L.8
Pommier, Y.9
-
37
-
-
49649095632
-
The binding orientation of a norindenoisoquinoline in the topoisomerase I-DNA cleavage complex is primarily foverned by pi-pi stacking interactions
-
Song, Y. L.; Cushman, M. The Binding Orientation of a Norindenoisoquinoline in the Topoisomerase I-DNA Cleavage Complex Is Primarily Foverned by pi-pi Stacking Interactions. J. Phys. Chem. B 2008, 112, 9484-9489.
-
(2008)
J. Phys. Chem. B
, vol.112
, pp. 9484-9489
-
-
Song, Y.L.1
Cushman, M.2
-
38
-
-
17144371295
-
Structures of three classes of anticancer agents bound to the human topoisomerase I-DNA covalent complex
-
Staker, B. L.; Feese, M. D.; Cushman, M.; Pommier, Y.; Zembower, D.; Stewart, L.; Burgin, A. B. Structures of Three Classes of Anticancer Agents Bound to the Human Topoisomerase I-DNA Covalent Complex. J. Med. Chem. 2005, 48, 2336-2345.
-
(2005)
J. Med. Chem.
, vol.48
, pp. 2336-2345
-
-
Staker, B.L.1
Feese, M.D.2
Cushman, M.3
Pommier, Y.4
Zembower, D.5
Stewart, L.6
Burgin, A.B.7
-
39
-
-
0037180432
-
The mechanism of topoisomerase i poisoning by a camptothecin analogue
-
Staker, B. L.; Hjerrild, K.; Feese, M. D.; Behnke, C. A.; Burgin, A. B.; Stewart, L. The Mechanism of Topoisomerase I Poisoning by a Camptothecin Analogue. Proc. Natl. Acad. Sci. U.S.A. 2002, 99 15387-15392
-
(2002)
Proc. Natl. Acad. Sci. U.S.A
, vol.99
, pp. 15387-15392
-
-
Staker, B.L.1
Hjerrild, K.2
Feese, M.D.3
Behnke, C.A.4
Burgin, A.B.5
Stewart, L.6
-
40
-
-
0030636777
-
Comparative molecular field analysis and molecular modeling studies of 20-(S)-camptothecin analogs as inhibitors of dna topoisomerase i and anticancer/antitumor agents
-
Carrigan, S.W.; Fox, P. C.; Wall, M. E.; Wani, M. C.; Bowen, J. P. Comparative Molecular Field Analysis and Molecular Modeling Studies of 20-(S)-Camptothecin Analogs as Inhibitors of DNA Topoisomerase I and Anticancer/Antitumor Agents. J. Comput. Aided Mol Des. 1997, 11, 71-78.
-
(1997)
J. Comput. Aided Mol Des.
, vol.11
, pp. 71-78
-
-
Carrigan, S.W.1
Fox, P.C.2
Wall, M.E.3
Wani, M.C.4
Bowen, J.P.5
-
41
-
-
0001739614
-
The synthesis of isoquinolines by the pomeranzfritsch reaction
-
Gensler, W. J. The Synthesis of Isoquinolines by the PomeranzFritsch Reaction. Org. React. 1951, 6, 191-206.
-
(1951)
Org. React.
, vol.6
, pp. 191-206
-
-
Gensler, W.J.1
-
42
-
-
0343909475
-
Synthesis of isoquinolines. IV. 4-Benzylisoquinolines
-
Bobbitt, J. M.; Winter, D. P.; Kiely, J. M. Synthesis of Isoquinolines. IV. 4-Benzylisoquinolines. J. Org. Chem. 1965, 30, 2459-2460.
-
(1965)
J. Org. Chem.
, vol.30
, pp. 2459-2460
-
-
Bobbitt, J.M.1
Winter, D.P.2
Kiely, J.M.3
-
43
-
-
37049142396
-
New modification of the pomeranz-fritsch isoquinoline synthesis
-
Birch, A. J.; Jackson, A. H.; Shannon, P. V. R. New Modification of the Pomeranz-Fritsch Isoquinoline Synthesis. J. Chem. Soc., Perkin Trans. 1 1974, 2185-2190.
-
(1974)
J. Chem. Soc., Perkin Trans.
, vol.1
, pp. 2185-2190
-
-
Birch, A.J.1
Jackson, A.H.2
Shannon, P.V.R.3
-
44
-
-
0001267078
-
Ortho metalation directed by alphaamino alkoxides
-
Comins, D. L.; Brown, J. D. Ortho Metalation Directed by AlphaAmino Alkoxides. J. Org. Chem. 1984, 49, 1078-1083.
-
(1984)
J. Org. Chem.
, vol.49
, pp. 1078-1083
-
-
Comins, D.L.1
Brown, J.D.2
-
45
-
-
0028906786
-
Some practical considerations and applications of the national cancer institute in vitro anticancer drug discovery screen
-
Boyd, M. R.; Paull, K. D. Some Practical Considerations and Applications of the National Cancer Institute in Vitro Anticancer Drug Discovery Screen. Drug Dev. Res. 1995, 34, 91-109.
-
(1995)
Drug Dev. Res.
, vol.34
, pp. 91-109
-
-
Boyd, M.R.1
Paull, K.D.2
-
46
-
-
33749011163
-
The NCI60 human tumour cell line anticancer drug screen
-
Shoemaker, R. H. The NCI60 Human Tumour Cell Line Anticancer Drug screen. Nat. Rev. Cancer 2006, 6, 813-823.
-
(2006)
Nat. Rev. Cancer
, vol.6
, pp. 813-823
-
-
Shoemaker, R.H.1
-
48
-
-
77949411688
-
-
version 8.0.3; Tripos: St. Louis, MO
-
SYBYL, version 8.0.3; Tripos: St. Louis, MO.
-
Sybyl
-
-
-
49
-
-
77949377788
-
-
version 3.0.1; The Cambridge Crystallographic Data Centre: Cambridge, U.K
-
GOLD, version 3.0.1; The Cambridge Crystallographic Data Centre: Cambridge, U.K.
-
Gold
-
-
-
50
-
-
0038626673
-
-
Gaussian, Inc.: Wallingford, CT
-
Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.; Robb, M. A.; Cheeseman, J. R.; Montgomery, J. A., Jr.; Vreven, T.; Kudin, K. N.; Burant, J. C.; Millam, J. M.; Iyengar, S. S.; Tomasi, J.; Barone, V.; Mennucci, B.; Cossi, M.; Scalmani, G.; Rega, N.; Petersson, G. A.; Nakatsuji, H.; Hada, M.; Ehara, M.; Toyota, K.; Fukuda, R.; Hasegawa, J.; Ishida, M.; Nakajima, T.; Honda, Y.; Kitao, O.; Nakai, H.; Klene, M.; Li, X.; Knox, J. E.; Hratchian, H. P.; Cross, J. B.; Bakken, V.; Adamo, C. Jaramillo, J.; Gomperts, R.; Stratmann, R. E.; Yazyev, O.; Austin, A. J.; Cammi, R.; Pomelli, C.; Ochterski, J. W.; Ayala, P. Y.; Morokuma, K.; Voth, G. A.; Salvador, P.; Dannenberg, J. J.; Zakrzewski, V. G.; Dapprich, S.; Daniels, A. D.; Strain, M. C.; Farkas, O.; Malick, D. K.; Rabuck, A. D.; Raghavachari, K.; Foresman, J. B.; Ortiz, J. V.; Cui, Q.; Baboul, A. G.; Clifford, S.; Cioslowski, J.; Stefanov, B. B.; Liu, G.; Liashenko, A.; Piskorz, P.; Komaromi, I.; Martin, R. L.; Fox, D. J.; Keith, T.; Al-Laham, M. A.; Peng, C. Y.; Nanayakkara, A.; Challacombe, M.; Gill, P. M. W; Johnson, B.; Chen, W.; Wong, M. W.; Gonzalez, C.; Pople, J. A. Gaussian 03; Gaussian, Inc.: Wallingford, CT, 2004.
-
(2004)
Gaussian 03
-
-
Frisch, M.J.1
Trucks, G.W.2
Schlegel, H.B.3
Scuseria, G.E.4
Robb, M.A.5
Cheeseman, J.R.6
Montgomery Jr., J.A.7
Vreven, T.8
Kudin, K.N.9
Burant, J.C.10
Millam, J.M.11
Iyengar, S.S.12
Tomasi, J.13
Barone, V.14
Mennucci, B.15
Cossi, M.16
Scalmani, G.17
Rega, N.18
Petersson, G.A.19
Nakatsuji, H.20
Hada, M.21
Ehara, M.22
Toyota, K.23
Fukuda, R.24
Hasegawa, J.25
Ishida, M.26
Nakajima, T.27
Honda, Y.28
Kitao, O.29
Nakai, H.30
Klene, M.31
Li, X.32
Knox, J.E.33
Hratchian, H.P.34
Cross, J.B.35
Bakken, V.36
Adamo, C.37
Jaramillo, J.38
Gomperts, R.39
Stratmann, R.E.40
Yazyev, O.41
Austin, A.J.42
Cammi, R.43
Pomelli, C.44
Ochterski, J.W.45
Ayala, P.Y.46
Morokuma, K.47
Voth, G.A.48
Salvador, P.49
Dannenberg, J.J.50
Zakrzewski, V.G.51
Dapprich, S.52
Daniels, A.D.53
Strain, M.C.54
Farkas, O.55
Malick, D.K.56
Rabuck, A.D.57
Raghavachari, K.58
Foresman, J.B.59
Ortiz, J.V.60
Cui, Q.61
Baboul, A.G.62
Clifford, S.63
Cioslowski, J.64
Stefanov, B.B.65
Liu, G.66
Liashenko, A.67
Piskorz, P.68
Komaromi, I.69
Martin, R.L.70
Fox, D.J.71
Keith, T.72
Al-Laham, M.A.73
Peng, C.Y.74
Nanayakkara, A.75
Challacombe, M.76
Gill, P.M.W.77
Johnson, B.78
Chen, W.79
Wong, M.W.80
Gonzalez, C.81
Pople, J.A.82
more..
|